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Pulsed laser deposition was proved as a suitable method for hydroxyapatite (HA) coating of coaxial poly-ε-caprolactone/poly-
vinylalcohol (PCL/PVA) nanoﬁbers. The ﬁbrous morphology of PCL/PVA nanoﬁbers was preserved, if the nanoﬁber scaﬀold was
coated with thin layers of HA (200nm and 400nm). Increasing thickness of HA, however, resulted in a gradual loss of ﬁbrous
character. In addition, biomechanical properties were improved after HA deposition on PCL/PVA nanoﬁbers as the value of
Young’s moduli of elasticity signiﬁcantly increased. Clearly, thin-layer hydroxyapatite deposition on a nanoﬁber surface stimulated
mesenchymal stem cell viability and their diﬀerentiation into osteoblasts. The optimal depth of HA was 800nm.
1.Introduction
Stem cells have undoubtedly been at the center of interest
and the object of intensive study in the last decade [1–3].
Clearly, multiple stem cells have, under suitable conditions,
the potential to diﬀerentiate cell lineages and thus play a key
role in tissue engineering and regenerative medicine. Several
sources of stem cells have been described, including muscle
[4, 5], synovium [6], periosteum [7], and bone marrow [8,
9]. Stem cells can be also isolated from adipose tissue, which
canbeobtainedunderlocalanesthesiawithminimaldiscom-
fort [10, 11]. However, bone marrow is most widely utilized
as a source of autologous MSCs. These cells can diﬀerentiate
into osteogenic lineages when cultured in the presence of
dexamethasone, ascorbic acid, and β-glycerophosphate [12]
and potentially used for treating large bone defects. Autol-
ogous stem cells as the source of donor cells have numerous
advantages for regenerative medicine. These include low do-
norsitemorbidity,adiminishedorabsentimmuneresponse,
and a high proliferative potential [1, 2].
Infact,othergrowthfactorssuchastransforminggrowth
factor (TGF-β), insulin-like growth factor (IGF), and basic
ﬁbroblast growth factor (bFGF) have been described as stim-
ulators of MSCs proliferation and osteogenic diﬀerentiation
[13, 14]. The process of stem cell diﬀerentiation is un-
doubtedly complicated and time and concentration depen-
dent. Thus, the main challenge of the successful application
of MSCs in regenerative medicine seems to be the regulated
release of a suitable concentration of diﬀerentiation factors,
particularlyunderinvivoconditions.Thisisamongthegoals2 Journal of Biomedicine and Biotechnology
of tissue engineering as a multidisciplinary ﬁeld focusing
on the reconstruction of biological tissues. Cells, especial-
ly autologous cells, and smart (functionalized) scaﬀolds en-
riched with growth factors, preferentially serving as a con-
trolled delivery device, are fundamental components in the
engineering of novel cell proliferation and diﬀerentiation
systems [2].
Surface modiﬁcation is one of the essential steps in con-
structing artiﬁcial cell-seeded systems. HA, which is similar
to the apatite of living bone, can be used as a suitable ma-
terialforimprovingcellproliferationanddiﬀerentiationinto
osteoblasts. HA has been used in medicine and dentistry
for over 20 years due to its biocompatibility and osteocon-
ductivity and its excellent chemical and biological aﬃnity
with bone tissue [15, 16]. HA coatings of bone implants
enable fast bony adaptation and reduced healing time [17–
19]. There are a number of techniques used to produce thin
HA ﬁlms. Plasma-sprayed HA coatings, where HA is bound
mechanically, have limited chemical bonding, and cracks,
pores, and other impurities limit their mechanical strength
in contact with a substrate and the stability of the layer
[20, 21]. Another coating technique is ion beam sputtering,
producing an amorphous coating. Subsequently, heat treat-
ment is necessary to produce crystals [22, 23]. Very high
temperatures, necessary for crystallization, are not favorable
f o rn o n m e t a l l i cm a t e r i a l ss u c ha sp o l ym e r so rb i o a c t i v em o l -
ecules. Pulsed laser deposition (PLD) is mostly used as an
alternative technique of HA coating [24, 25]. PLD employs
an intense laser beam for material evaporation. Subsequent
condensation on a mat can create a very thin layer (depth of
severalatomsonly).Thematerialsurfacepropertiesare,con-
sequently, directly dependent on the deposition conditions.
Aside from chemical and surface charge modiﬁcation,
the surface’s physical properties are also vital for successful
cell seeding on scaﬀolds. Nanotechnology is the term used to
cover the design, construction, and utilization of functional
structures with at least one characteristic dimension mea-
sured in nanometers and brings a new chance to stem cells
research and development [26–28].
Electrospun nanoﬁbers are novel materials characterized
by an enormous surface to volume ratio, high porosity, and
a structure resembling that of the extracellular matrix, thus
facilitating their use in a broad range of applications [29, 30].
These properties predestined the use of nanoﬁbers in various
tissue engineering applications. In addition, nanoﬁbers can
also serve as drug delivery systems. Nanoﬁbers have been
utilized for the delivery of both water soluble and water
insoluble substances [31, 32]. Due to their enormous surface
area, nanoﬁbers enable the adhesion of diverse bioactive
agents, such as growth factors [33], enzymes [34], or nucleic
acids [35]. The release kinetics of the content is determined
by the form of the interaction between the ﬁbers and the
adhered drug. If the drug is noncovalently attached to the
nanoﬁber surface, the interaction is weak, and a quick burst
release occurs. For nonbiodegradable materials, the diﬀu-
sion rate of the drug from the ﬁbers depends strongly on
the physiochemical properties of the delivered substances,
such as the molecular weight, hydrophobicity, and charge
of the molecule. For biodegradable materials, the process
additionally depends also on the kinetics of the material’s de-
gradation, which for rapidly degradable materials is signiﬁ-
cantly hastened [29]. Clearly, drugs dissolved or dispersed in
materialsfromwhichnanoﬁbersareproducedcanbequickly
released. However, healing processes often require a slower
release on a scale of days or even weeks. This is especially
important in vivo.
To overcome this obstacle, the incorporation of bioac-
tive substances in the interior of the nanoﬁber has been
employed. This can be achieved either by blend electrospin-
ning or by coaxial electrospinning. Blend electrospinning is
a single-step method enabling the incorporation of various
bioactive substance [32]. The disadvantage of the process is
its limitation by the compatibility of the delivered substances
with the polymer solvent. Thus, blend electrospinning is not
suitable for the delivery of proteins with polymers soluble
only in organic solvents. Despite these constraints, blend
electrospinning is a fast and convenient method for the
microencapsulation of antibiotics [36, 37], anticancer drugs
[38–42], proteins [43–45], DNA [46, 47], and siRNA [48].
Recently, coaxial electrospinning was introduced as a novel
methodfordrugdeliveryresultingintheproductionofcore-
shell nanoﬁbers [49]. The nanoﬁber core and shell could
be prepared either from the same polymer solution or from
diﬀerent polymer solutions, thus combining the advantages
of both polymer systems. Such systems could deliver highly
susceptive substances in combination with various polymer
systems without altering their structure or function. Electro-
spun coaxial ﬁbers have been employed for the delivery of
various bioactive substances, for example, proteins [50–52],
DNA [46], and siRNA [48]. In addition, further drug encap-
sulation in the nanoﬁber core, such as in liposomes, can sig-
niﬁcantly prolong drug release from the nanoﬁber interior.
The aim of the present study was to introduce a modern
system suitable for the treatment of bone defects. This sys-
temisbasedonMSCsandfunctionalizednanoﬁbers.Thena-
noﬁbers can be modiﬁed on their surface as well as enriched
intheircorewithdiﬀerentdrugsthatcouldbeslowlyreleased
over the course of days or weeks.
2. Methods
2.1. Materials and Reagents. Poly-ε-caprolactone (PCL, MW
45000), FITC-dextran, MTT, glycerol 2-phosphate disodium
salt hydrate, BCECF-AM, and PCR primers were purchased
from Sigma-Aldrich (Germany). Polyvinylalcohol sloviol
(PVA) was purchased from Novacke Chemicke Zavody
(Slovak republic). Hydroxyapatite was obtained in the form
of a pressed powder (Lasak, Czech Republic). Gelofusine was
purchased from B. Braun Melsungen (Germany). α-MEM
cultivation medium and foetal bovine serum were purchased
from PAA (Austria). Double-strand-speciﬁc dye for PCR
analysis, SYBR Green I, was purchased from Roche (Roche
Diagnostics, Mannheim, Germany) and an RNeasy Mini Kit
for RNA isolation from Qiagen (Germany).
2.2. Coaxial Electrospinning of PCL/PVA Nanoﬁbers. A 14%
(w/v) PCL solution was prepared as the shell solution by
dissolving 7g PCL in 50mL chloroform/ethanol (8:2) andJournal of Biomedicine and Biotechnology 3
stirring at room temperature. The core solution consisted
of 5% PVA (v/v). The coaxial spinneret apparatus consisted
of two needles placed together coaxially [53]. Two syringe
pumps were used to deliver the core and shell solutions, re-
spectively. A high-voltage power supply was used to generate
voltages of up to 60kV, and a span bond was used as the re-
ceiving plate to collect the electrospun nanoﬁbers. The dis-
tance between the tip of the syringe needle and the collecting
plate was 12cm. All electrospinning processes were per-
formed at room temperature with 56% humidity. In case of
thereleasestudy,thecoresolutionconsistedofFITC-dextran
(2mg/mL, 10,000 MW) dissolved either in 1%, 3%, or 5%
(v/v) PVA. The process was performed on the apparatus de-
scribed above at room temperature with 52% humidity.
2.3. HA Coatings of Nanoﬁbers. Prepared nanoﬁbers
were coated by HA layers of diﬀerent thickness. HA
[Ca10(PO4)6(OH)2]ﬁ l m sw e r ec r e a t e db yaK r Fe x c i m e r
laser (COMPexPro 205 F) of 248nm wavelength, frequency
10Hz, and energy 600mJ. The energy density of the laser
beam was 2 Jcm−2. The deposition proceeded in an H2O+
Ar atmosphere at a pressure of 40Pa. The substrate was ﬁxed
at a distance of 5cm from the target HA material (cake of
pressed powder). The substrate was at room temperature.
HA ﬁlms of 200 (PCL/PVA200HA), 400 (PCL/PVA400HA),
and 800nm thickness (PCL/PVA800HA) were grown. Pure
PCL/PVA core-shell nanoﬁbers were used as a control (PCL/
PVA).
2.4. Characterization of the Scaﬀolds. The prepared nanoﬁ-
brous scaﬀolds were characterized by scanning electron mi-
croscopy. Air-dried samples of electrospun HA-coated nano-
ﬁbers were mounted on aluminum stubs and sputter-coated
with a layer of gold approximately 60nm thick using a
Polaronsputter-coater(SC510,Polaron,NowQuorumTech-
nologies Ltd.). The samples were examined in an Aquasem
(Tescan)scanningelectronmicroscopeinthesecondaryelec-
tron mode at 15kV.
2.5. Biomechanical Characterization of Scaﬀolds. Young’s
moduli of elasticity, ultimate stresses, and ultimate strains
of the scaﬀolds were obtained at room temperature using a
Zwick/Roelltractionmachineequippedwitha1kNloadcell.
Because of the diﬃculty to produce the layer of PCL/PVA na-
noﬁbers of uniform thickness, only the samples with the
same thickness of the basic layer of PCL/PVA nanoﬁbers of
pure samples as well as with the layer of HA were used for
mechanical testing. Thus, the samples without layer of HA
w e r es i g n e da st y p eI( n = 4) and with the HA layer as
type II (n = 7). The samples themselves were thin strips of
the nanoﬁbers. The initial length of all samples was 10mm.
The width of all samples was 10mm. The thickness of in-
dividual samples was about 60μm. The samples were pre-
paredaccordingtostudies[54,55].Thetemplateofthepaper
20 × 50mm (height × width) with the centered rectangular
hole 10 × 40mm was cut, and lines marking 10mm wide
samplestripsweredrawnonitstopandbottomstripes.Then
it was glued to the sheet of the composite, and two other
strips of paper 5 × 50mm were glued to the back faces of the
top and bottom stripes. Then the individual scaﬀolds were
cut resulting in four 20 × 10mm stripes consisting of 10 ×
10mm sample between two 5 × 10mm grips of paper.
Thetensiletestwithaloadingvelocityof10mm/minwas
applied to the samples. The load was applied until the scaf-
fold ruptured. Young’s moduli of elasticity were determin-
ed using linear regression of the stress-strain curves at a
strain of approximately 1–6% (linear region depending on
the shape of the curve). The ultimate stress and the ultimate
strain were determined at the start of the rupture. The stress
was deﬁned as the force divided by the initial area, and the
strain was deﬁned as the elongation of the specimen divided
byitsinitiallength.OurownsoftwarewritteninPythonpro-
gramming language was used for evaluation [56].
2.6. Isolation and Cultivation of MSCs. B l o o dm a r r o wa s p i -
rates were obtained from the os ilium (tuber coxae Ala ossis
iili) of anesthetized miniature pigs (age 6–12 months). The
bone marrow blood was aspirated into a 10mL syringe with
5mL Dulbecco’s phosphate buﬀered saline (PBS), 2% fetal
bovine serum (FBS), and 25IU heparin/mL connected with
a bioptic needle (15G/70mm). Under sterile conditions, the
bone marrow blood (about 20mL) was placed into 50mL
centrifuge tubes and 5mL of gelofusine was added. After
30min incubation at room temperature, the blood was cen-
trifuged at 400×g for 15min. Subsequently, the layer of mo-
nonuclear cells was removed and seeded into a culture ﬂask,
then cultured at 37◦C in a humidiﬁed atmosphere with 5%
CO2. α-MEM medium with Earle’s Salt and L-glutamine
supplemented with 10% FBS and penicillin/streptomycin
(100IU/mL and 100μg/mL, resp.) was used as the culture
medium.
2.7. MSCs Seeding on the Scaﬀolds. Scaﬀolds were cut into
a round shape with a diameter of 6mm and sterilized using
ethylenoxid. Cells were seeded on the scaﬀolds at a density
of 70 × 103/cm2 in a 96-well plate. Scaﬀolds with seeded
MSCs were cultivated in diﬀerentiation media: α-MEM sup-
plemented with 10% FBS, penicillin/streptomycin (100IU/
mL and 100μg/mL, resp.), 100nM dexamethasone, 40μg/
mL ascorbic acid-2-phosphate and 10nM glycerol 2-phos-
phate disodium salt hydrate. The medium was changed ev-
ery 3 days.
2.8. Cell Proliferation Analysis by the MTT Test. 50μLo f
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide] (MTT), and 1mg/mL in PBS (pH 7.4) were added
to 150μL of sample medium and incubated for 4 hours at
37◦C. The MTT was reduced by the mitochondrial dehydro-
genase of normally metabolizing cells to purple formazan.
Formazan crystals were solubilized with 100μL of 50% N,N-
dimethylformamide in 20% sodium dodecyl sulfate (SDS) at
pH 4.7. The results were examined by spectrophotometry in
an ELISA reader at 570nm (reference wavelength 690nm).
2.9. Cell Proliferation Analysis by PicoGreen. The PicoGreen
assay was carried out using the Invitrogen PicoGreen assay
kit (Invitrogen Ltd., Paisley, UK). The proliferation of MSCs
on scaﬀolds was tested on days 1, 7, and 14. To process4 Journal of Biomedicine and Biotechnology
material for the analysis of DNA content, 250μLo fc e l l
lysis solution (0.2% v/v Triton X-100, 10mM Tris (pH 7.0),
1mM EDTA) was added to each well containing a scaf-
fold sample. To prepare the cell lysate, the samples were pro-
cessed through a total of three freeze/thaw cycles, scaﬀold
sample was ﬁrst frozen at −70◦Ca n dt h a w e da tr o o mt e m -
perature. Between each freeze/thaw cycle scaﬀolds were
roughly vortexed. Prepared samples were stored at −70◦C
until analysis. To quantify cell number on scaﬀo l d s ,ac e l l -
based standard curve was prepared using samples with
knowncellnumbers(range100–106 cells).TheDNAcontent
was determined by mixing of 100μL PicoGreen reagent and
100μL of DNA sample. Samples were loaded in triplicate
and ﬂorescence intensity was measured on a multiplate ﬂuo-
rescence reader (Synergy HT, λex = 480–500nm, λem = 520–
540nm). Measured data were used for derivation of ab-
sorbance values measured by MTT assay to cell counts on
the scaﬀolds.
2.10. Viability of Cells Seeded on Scaﬀolds. For determining
cell viability, live/dead staining (BCECF-AM/propidium io-
dide) and visualization using confocal microscopy was per-
formed. 2 ,7  -bis(2carboxyethyl)-5(6)-carboxyﬂuorescein
acetoxymethylester(BCECF-AM,diluted1:100inmedium)
was added to cell-seeded scaﬀolds and incubated for 45min
at 37◦C and 5% CO2 for live cell detection, then rinsed with
PBS (pH 7.4); propidium iodide (5μg/mL in PBS pH 7.4)
was added for 10min, rinsed with PBS (pH 7.4) again, and
visualized using a Zeiss LSM 5 DUO confocal microscope
(wavelengths: BCECF-AM λexc = 488nm and λem = 505–
535nm; propidium iodide λexc = 543nm and λem = 630–
700nm).
2.11. Quantitative Real-Time PCR Analysis. Total RNA was
extracted using an RNeasy Mini Kit according to the manu-
facturer’s protocol. Total RNA was stored at –20◦C.
The cDNA from 1μg of total RNA was used as a tem-
plate. The synthesis of cDNA was performed by a standard
procedure described in our previous work [57]. Bone sialo-
protein (BS) and osteocalcin (OC) mRNA expression levels
were quantiﬁed by means of a LightCycler 480 (Roche Dia-
gnostics, Mannheim, Germany) using the double-strand-
speciﬁc dye SYBR Green I according to the manufacturer’s
protocol. Primers used were as follows: BS, sense 5 -CGA
CCA AGA GAG TGT CAC-3 , antisense 5 -GCC CAT TTC
TTG TAG AAG C-3  (498bp); OC, sense 5 -TCA ACC CCG
ACT GCG ACG AG-3 , antisense 5 -TTG GAG CAG CTG
GGA TGA TGG-3  (204bp) and beta-actin, sense 5 -AGG
CCA ACC GCG AGA AGA TGA CC-3 , antisense 5 -GAA
GTC CAG GGC GAC GTA GCA C-3  (332bp). The PCR
conditions were initial denaturation at 95◦C for 10min, fol-
lowedby45cyclesofdenaturationat95◦Cfor15s,annealing
at 57◦C for 10s, and extension at 72◦Cf o r2 0 s .T h ee x -
pression levels of BS and OC mRNAs were normalized using
the level of beta-actin mRNA as a housekeeping gene and
expressed as the ratio to actin. Student’s t-test was used to
evaluate the statistical signiﬁcance of the results. Diﬀerences
with P values <0.05 were considered signiﬁcant.
2.12. Measurement of FITC-Dextran Release Proﬁle. In order
to study the release proﬁle of FITC-dextran, core-shell nano-
ﬁber meshes with either 1% PVA, 3% PVA, or 5% PVA were
cut into round patches and incubated with 1mL of TBS
buﬀer at room temperature. At speciﬁc intervals, the TBS
buﬀer was withdrawn and replaced with fresh buﬀer. The
time interval was determined keeping in mind the balance
between the release of a detectable amount of FITC-dextran
and maintenance of the sink condition. Drug release was
quantiﬁed using ﬂuorescence spectroscopy. Brieﬂy, 200μLo f
samples and blank samples were measured on a multiplate
ﬂuorescence reader (Synergy HT, λex = 480–500nm, λem =
520–540nm) and background subtraction was performed.
ThecumulativereleaseproﬁleofFITC-dextranwasobtained,
and the half time of release was determined as the time at
which the initial ﬂuorescence intensity I0 decreased to I =
I0 ·e−1.
2.13. Statistical Analysis. Quantitative data are presented as
mean ± standard deviation (SD). For in vitro tests, average
values were determined from at least three independently
prepared samples. Results were evaluated statistically using
one-way analysis of variance (ANOVA) and the Student-
Newman-KeulsMethod.TheShapiro-Wilk’sW testwasused
to determine the normality of the Young’s moduli of elas-
ticity, ultimate strains, and ultimate stresses. The t-test was
used to determine the diﬀerences between values of mech-
anicalparametersobtainedforpurePCL/PVAscaﬀolds(type
I) and scaﬀolds covered by HA (type II).
3. Results and Discussion
3.1. Scaﬀold Characterization. Coaxial core-shell nanoﬁbers
were prepared from PCL as a shell material and PVA as a core
material.PCLhasgoodbiocompatibilityandenablesthesuc-
cessfulcultivationofMSCs[58]andosteogeniccells[59].On
the other hand, PVA is a water-soluble material and has been
employed as a suitable substance for the delivery of bioactive
compounds from the nanoﬁber core [60]. To improve the
surface parameters for MSCs seeding, coaxial nanoﬁbers
werefurtherfunctionalizedbypulsedlaserdepositionofHA.
Thin layers of 200, 400, or 800nm thickness were deposited
onto the nanoﬁber surface. HA deposition clearly modiﬁed
the nanoﬁber surface and signiﬁcantly inﬂuenced the surface
properties. Scanning electron microscopy revealed the
ﬁbrous morphology of PCL nanoﬁbers (Figure 1(a)). This
is in accordance with our previous results [61]. Pulsed laser
deposition of a 200nm thick HA layer did not aﬀect the ﬁ-
brous morphology or porosity of the nanoﬁbers (Figure
1(b)). However, the ﬁbrous character of samples with a
400nm thick HA layer (Figure 1(c)) was less well preserved,
and the porosity of the scaﬀold decreased. The ﬁbrous mor-
phology disappeared completely in samples with a 800nm
thick HA coating (Figure 1(d)).
3.2. Biomechanical Testing. The eﬀect of an HA layer on the
biomechanical properties of the nanoﬁbers was tested us-
ing a tensile test. Young’s moduli of elasticity, the ultimate
stresses, and the ultimate strains of scaﬀolds of PCL/PVAJournal of Biomedicine and Biotechnology 5
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Figure 1: Visualization of scaﬀolds by SEM and confocal microscopy. Prepared scaﬀolds were visualized using SEM (a, b, c, d). On day 7,
MSCs were stained using BCECF-AM and propidium iodide for live/dead staining, and samples were visualized by confocal microscopy (e,
f, g, h); PCL/PVA (a, e), PCL/PVA200HA (b, f), PCL/PVA400HA (c, g), and PCL/PVA800HA (d, h).
nanoﬁbers and various amounts of HA were determined at
room temperature using a Zwick/Roell traction machine. We
found signiﬁcant diﬀerences in Young’s moduli of elasticity
between samples without an HA layer and those with an HA
layer (P = 0.04). Young’s moduli of elasticity in the case of
pure PCL/PVA nanoﬁbers was 1.76 ± 0.50Mpa while that
for the samples with an HA layer was 5.40 ± 3.09MPa; the
diﬀerencewassigniﬁcant(seeFigure 4(a)).Signiﬁcantdiﬀer-
encesbetweenthesetwogroupswerefoundaswellinthecase
of ultimate strains (P<0.001). Here, the value obtained for
pure PCL/PVA scaﬀolds was 0.23 ± 0.03, while for scaﬀolds
with an HA layer the value was 0.09±0.04, (see Figure 4(b)).
No signiﬁcant diﬀerences were found when analyzing ulti-
mate stresses (P = 0.26), although the value for the
g r o u pw i t ha nH Al a y e r ,0 . 3 6± 0.27MPa, was higher than
that for the pure PCL/PVA scaﬀolds, 0.19 ± 0.07MPa (see
Figure 4(c)). The results showed that from the mechanical
point of view, a PCL/PVA scaﬀolds covered by an HA layer
is the relevant choice as a scaﬀold material for other studies
and applications in which greater stiﬀness is required.
3.3. Proliferation and Viability of MSCs Seeded on Scaﬀolds.
To test the scaﬀolds’ biocompatibility and their ability to
stimulate the proliferation and diﬀerentiation of MSCs into
osteogenic cells, MSCs were seeded on scaﬀolds and culti-
vatedfor14days.Theirproliferationandviabilityweredeter-
minedondays1,7,and14.Cellproliferationwasdetermined
by the PicoGreen assay and confocal microscopy (Figure 2).
Viability was determined by the widely used MTT assay.
Clearly, the deposition of a 400nm or 800nm thick HA layer
resulted in the highest absorbance, which in turn reﬂected
the best cell viability. However, some publications have
reported that the MTT test is aﬀected by cell number [62]. In
order to correct for the possible inaccuracy of the MTT as-
say, we performed the PicoGreen assay as well. PicoGreen is
a highly sensitive probe for dsDNA and thus can be used to
determine cell numbers. Consequently, we performed both
the MTT assay and the PicoGreen assay and correlated both
results. This approach enabled the calibration of the absor-
bance measured in the MTT assay to the cell number deter-
mined by PicoGreen. By comparing the results of both assays
in this manner, we were able to derive reliable data on cell
viability (Figure 2). The results showed that in the control
samples (PCL/PVA), cell viability was only slightly elevated.
On the other hand, samples coated with HA showed a mark-
ed increase in cell viability. The highest viability was detected
for samples with a 400nm or 800nm thick HA coating.
This conclusion was clearly supported by our confocal
microscopy observations. MSC viability on the scaﬀolds was
characterized by BCECF-AM and propidium iodide in the
presence of an HA coating (Figures 1(e)–1(h)). The largest
cell population was found in the samples with an 800nm
thick HA coating (Figure 1(h)), which is in agreement with
the results of the PicoGreen assay.
3.4. Osteogenic Diﬀerentiation of MSCs. A positive inﬂuence
of HA on osteogenesis has been demonstrated in many re-
ports [4, 63, 64]. On the other hand, Wang et al. pointed out
the signiﬁcance of HA structures for proliferation and found
higher cell proliferation rates on microsized HA particles
than on nanosized ones [65]. Ribeiro et al. also found
improved cell viability and proliferation of osteoblastic6 Journal of Biomedicine and Biotechnology
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Figure 2: Cell metabolic activity and viability. Metabolic activity of viable MSCs was detected by MTT assay on day 1, 7, and 14 (mean ±
standard deviation). Results of MTT assay for PCL/PVA, PCL/PVA200HA, PCL/PVA400HA, and PCL/PVA800HA samples (a). Cell viability
calculated as derivation of absorbance values from MTT assay to cell counts determined by PicoGreen assay (b).
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Figure 3: Expression of BS (a) and OC (b) genes. Osteogenic diﬀerentiation of MSCs was detected by PCR analysis of expresion BS and OC
genes on day 7 and 14 (mean ± standard deviation).
MC3T3-E1 cells on HA particles of larger size [66]. However,
there is no clear evidence so far on the eﬀect of HA on diﬀer-
entiation into osteogenic cells. Therefore, the eﬀect of HA
coating of nanoﬁbers on the osteogenic diﬀerentiation of
MSCs was studied using real-time PCR analysis. The expres-
sion levels of BS and OC mRNAs, osteogenic markers, were
detected on day 7 and 14 for all samples (Figures 3(a) and
3(b)). Interestingly, the samples with an 800nm thick HA
coating were characterized by the signiﬁcantly higher expres-
sion of BS and OC genes than the pure PCL/PVA samples.
Based on our results, we can hypothesize that HA-modiﬁed
nanoﬁbersinducedcelldiﬀerentiationandalsoimprovedcell
viability (Figure 2).
3.5. Release Proﬁle of FITC-Dextran. Besides surface modif-
ications, possibilities exist for drug distribution into the
nanoﬁber core. The encapsulation of diﬀerent proliferation
agentsinsidethenanoﬁberscanincreasetheirabilitytostim-
ulate proliferation and thus further improve the positive
eﬀect of nanoﬁber scaﬀolds on MSCs proliferation and dif-
ferentiation. This could be especially important in combi-
nation with the already described positive eﬀect of HA de-
positiononMSCsviabilityanddiﬀerentiation.Knowledgeof
the release proﬁle from HA-coated nanoﬁbers seems to be a
key point for the construction of novel drug-delivery systems
suitable for bone tissue engineering.
To study the release proﬁle from coaxially electrospun
nanoﬁbers with diﬀerent concentrations of core polymer,
FITC-dextran incorporated into the nanoﬁber core was
employed as the monitoring ﬂuorescence probe. The FITC-
dextran samples were incubated at room temperature in TBS
buﬀer, which was subsequently replaced with fresh buﬀer asJournal of Biomedicine and Biotechnology 7
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Figure 4: The moduli of elasticity, the ultimate strain, and ultimate stress of the group of pure PCL/PVA composite (type I) and the group
of the PCL/PVA composite covered by HA layer (type II). There is a signiﬁcant diﬀerence in the moduli of elasticity between these groups
(determined by t-test; P = 0.04) (a) and also in the ultimate strain (P<0.001) (b), but not in the ultimate stress (P = 0.26) (c). Mean is the
mean value, SE is the standard error.
described in Section 2. The collected fractions were analyzed
byﬂuorescencespectroscopy,andthecumulativereleasepro-
ﬁle of FITC-dextran was calculated (Figure 5). The half-time
of release from coaxial nanoﬁbers was strongly dependent
on the presence of a hydrophilic core polymer. Core/shell
nanoﬁbers containing FITC-dextran dissolved in 1% PVA
showed the highest burst release (79% of FITC-dextran
released in 24h). The half time of release was calculated as
τr = 18h. The release of FITC/dextran from ﬁbers with
3% PVA showed a slower release; however, an intense burst8 Journal of Biomedicine and Biotechnology
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Figure 5: Time-dependent release proﬁle of coaxial PCL/PVA na-
noﬁbers. Release of FITC-dextran from samples with diﬀerent con-
tent of PVA core was analyzed using ﬂuorescence spectroscopy.
Samples were analyzed for 240h, and supernatants were collected
in 24h intervals (mean ± standard deviation).
release was observed (65% of FITC-dextran released in 24h).
The half-time of release was prolonged to 24h. Interestingly,
samples with 5% PVA as the core polymer showed the most
sustained release proﬁle. The burst release was reduced to
52% of FITC-dextran release in 24h, and the half-time of
release was shifted to 54h. The results clearly show that dif-
ferent concentrations of the water-soluble core signiﬁcantly
aﬀect the release proﬁles of incorporated substances.
4. Conclusion
Pulsed laser deposition was proven to be a suitable method
for HA coating of coaxial PCL/PVA nanoﬁbers. The ﬁbrous
morphology of PCL/PVA nanoﬁbers was preserved when
the nanoﬁber scaﬀold was coated with thin layers of HA
(200nm and 400nm). Increasing the thickness of HA,
however, resulted in a gradual loss of this ﬁbrous character.
In addition, the biomechanical properties were improved
after HA deposition on PCL/PVA nanoﬁbers as the value of
Young’s moduli of elasticity signiﬁcantly increased after HA
deposition.
The proliferation and diﬀerentiation of MSCs on HA-
coated scaﬀolds are separate processes. Our HA-coated na-
noﬁber scaﬀolds clearly displayed a positive eﬀect on the dif-
ferentiationofMSCsintoosteogeniccellsbutnotoncellpro-
liferation. The moderate eﬀect of HA-coated nanoﬁber scaf-
folds on cell proliferation observed in our study could be im-
proved, however, by exploiting core/shell nanoﬁbers. Such a
delivery system, based on coaxial spinning, can encapsulate
proliferation stimulating factors that could be subsequently
steadily released. This system seems to be a potentially pro-
mising one for the development of artiﬁcial bone tissue and
bone healing. To conclude, thin-layer hydroxyapatite depo-
sition on a nanoﬁber surface stimulated mesenchymal stem
cell proliferation and their diﬀerentiation into osteoblasts.
The 800nm HA layer was demonstrated to be optimal for
bone tissue engineering application.
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